Home › Lipoid Nephrosis › Texas › Houston
Lipoid Nephrosis clinical trials in Houston, TX
4 studies for Lipoid Nephrosis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
Nephrotic Syndrome Study Network
RecruitingObservational study
- Texas Children's Hospital - Baylor College of Medicine, Houston
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Texas Children's Hospital, Houston
Lipoid Nephrosis trials in other cities
- Philadelphia, PA5 studies
- Queens, NY5 studies
- Ann Arbor, MI5 studies
- Durham, NC4 studies
- Atlanta, GA4 studies
- Los Angeles, CA3 studies
- Seattle, WA3 studies
- Kansas City, MO3 studies
- New York City, NY3 studies
- Chicago, IL3 studies
- Cleveland, OH3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.